Skip to main content
  • 586 Accesses

In this chapter, we develop a simple double marginalization model with complete information, in which an original manufacturer of a pharmaceutical product faces potential competition from parallel imports by a foreign exclusive distributor. The model suggests that parallel imports will never occur in the sub-game perfect Nash equilibrium, as it will always be beneficial for the manufacturer to monopolize the home country by undercutting the price of the re-imported pharmaceutical product. However, the question as to whether it is optimal for the manufacturer to charge the monopoly price in the home country depends on the level of trade costs and the level of heterogeneity of the two countries, in terms of market size and price elasticity of demand.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Gabler | GWV Fachverlage GmbH

About this chapter

Cite this chapter

Müller-Langer, F. (2009). Legal and Economic Analysis of Parallel Imports. In: Creating R&D Incentives for Medicines for Neglected Diseases. Gabler. https://doi.org/10.1007/978-3-8349-8323-7_5

Download citation

Publish with us

Policies and ethics